These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34789839)

  • 21. Regulation of neuroblastoma migration, invasion, and in vivo metastasis by genetic and pharmacological manipulation of MDA-9/Syntenin.
    Bhoopathi P; Pradhan AK; Bacolod MD; Emdad L; Sarkar D; Das SK; Fisher PB
    Oncogene; 2019 Oct; 38(41):6781-6793. PubMed ID: 31406249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CHD5, a tumor suppressor that is epigenetically silenced in lung cancer.
    Zhao R; Yan Q; Lv J; Huang H; Zheng W; Zhang B; Ma W
    Lung Cancer; 2012 Jun; 76(3):324-31. PubMed ID: 22186629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The involvement of CHD5 hypermethylation in laryngeal squamous cell carcinoma.
    Wang J; Chen H; Fu S; Xu ZM; Sun KL; Fu WN
    Oral Oncol; 2011 Jul; 47(7):601-8. PubMed ID: 21636313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of CHD5 in human cancers: 10 years later.
    Kolla V; Zhuang T; Higashi M; Naraparaju K; Brodeur GM
    Cancer Res; 2014 Feb; 74(3):652-8. PubMed ID: 24419087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
    Zhao R; Wang N; Huang H; Ma W; Yan Q
    Liver Int; 2014 Jul; 34(6):e151-60. PubMed ID: 24529164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of neuroblastoma bone invasion/metastasis in established bone metastatic model of SY5Y and KCNR cell lines.
    Zhao H; Cai W; Li S; Da Z; Sun H; Ma L; Lin Y; Zhi D
    Childs Nerv Syst; 2013 Jul; 29(7):1097-105. PubMed ID: 23559392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SENP1 regulates cell migration and invasion in neuroblastoma.
    Xiang-Ming Y; Zhi-Qiang X; Ting Z; Jian W; Jian P; Li-Qun Y; Ming-Cui F; Hong-Liang X; Xu C; Yun Z
    Biotechnol Appl Biochem; 2016 May; 63(3):435-40. PubMed ID: 25816890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system.
    Thompson PM; Gotoh T; Kok M; White PS; Brodeur GM
    Oncogene; 2003 Feb; 22(7):1002-11. PubMed ID: 12592387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The CXCR4/CXCR7/CXCL12 Axis Is Involved in a Secondary but Complex Control of Neuroblastoma Metastatic Cell Homing.
    Mühlethaler-Mottet A; Liberman J; Ascenção K; Flahaut M; Balmas Bourloud K; Yan P; Jauquier N; Gross N; Joseph JM
    PLoS One; 2015; 10(5):e0125616. PubMed ID: 25955316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The chemokine receptor CXCR4 strongly promotes neuroblastoma primary tumour and metastatic growth, but not invasion.
    Meier R; Mühlethaler-Mottet A; Flahaut M; Coulon A; Fusco C; Louache F; Auderset K; Bourloud KB; Daudigeos E; Ruegg C; Vassal G; Gross N; Joseph JM
    PLoS One; 2007 Oct; 2(10):e1016. PubMed ID: 17925864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased expression of chromodomain helicase DNA-binding protein 5 is an unfavorable prognostic marker in patients with primary gallbladder carcinoma.
    Du X; Wu T; Lu J; Zang L; Song N; Yang T; Zhao H; Wang S
    Clin Transl Oncol; 2013 Mar; 15(3):198-204. PubMed ID: 22855185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations of 1p genes do not consistently abrogate tumor suppressor functions in 1p-intact neuroblastoma.
    Kuick CH; Tan JY; Jasmine D; Sumanty T; Ng AYJ; Venkatesh B; Chen H; Loh E; Jain S; Seow WY; Ng EHQ; Lian DWQ; Soh SY; Chang KTE; Chen ZX; Loh AHP
    BMC Cancer; 2022 Jun; 22(1):717. PubMed ID: 35768791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bin1 is linked to metastatic potential and chemosensitivity in neuroblastoma.
    Zhong X; Hoelz DJ; Kumar HR; Sandoval JA; Rescorla FJ; Hickey RJ; Malkas LH
    Pediatr Blood Cancer; 2009 Sep; 53(3):332-7. PubMed ID: 19418541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chd5 requires PHD-mediated histone 3 binding for tumor suppression.
    Paul S; Kuo A; Schalch T; Vogel H; Joshua-Tor L; McCombie WR; Gozani O; Hammell M; Mills AA
    Cell Rep; 2013 Jan; 3(1):92-102. PubMed ID: 23318260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential RNA Expression Between Metastatic and Primary Neuroblastoma Cells.
    Lee WG; Asuelime GE; Asuelime-Smith MBT; Chen SY; Kim ES
    J Surg Res; 2024 Jun; 298():240-250. PubMed ID: 38631173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA‑451 inhibits neuroblastoma proliferation, invasion and migration by targeting macrophage migration inhibitory factor.
    Liu G; Xu Z; Hao D
    Mol Med Rep; 2016 Mar; 13(3):2253-60. PubMed ID: 26783235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer.
    Hall WA; Petrova AV; Colbert LE; Hardy CW; Fisher SB; Saka B; Shelton JW; Warren MD; Pantazides BG; Gandhi K; Kowalski J; Kooby DA; El-Rayes BF; Staley CA; Volkan Adsay N; Curran WJ; Landry JC; Maithel SK; Yu DS
    Oncogene; 2014 Nov; 33(47):5450-6. PubMed ID: 24276239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNA SNHG7 promotes neuroblastoma progression through sponging miR-323a-5p and miR-342-5p.
    Jia J; Zhang D; Zhang J; Yang L; Zhao G; Yang H; Wang J
    Biomed Pharmacother; 2020 Aug; 128():110293. PubMed ID: 32534305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for Glioma.
    Xu L; Shao F; Luo T; Li Q; Tan D; Tan Y
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of CDKL1 suppresses neuroblastoma cell proliferation, migration and invasion.
    Li W; Cao J; Liu J; Chu W; Zhang C; Chen S; Kang Z
    Cell Mol Biol Lett; 2019; 24():19. PubMed ID: 30891073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.